EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 81 filers reported holding EIDOS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $397,108 | +103.0% | 3,018 | -22.1% | 0.01% | +100.0% |
| Q3 2020 | $195,652 | +6.0% | 3,872 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $184,578 | -2.7% | 3,872 | 0.0% | 0.00% | -25.0% |
| Q1 2020 | $189,689 | -14.6% | 3,872 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $222,214 | +59.5% | 3,872 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $139,276 | -26.7% | 3,872 | -36.7% | 0.00% | -33.3% |
| Q2 2019 | $190,023 | +32.5% | 6,114 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $143,373 | – | 6,114 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,123,630 | $56,777,000 | 18.14% |
| Board of Trustees of The Leland Stanford Junior University | 265,670 | $13,425,000 | 5.17% |
| Opaleye Management Inc. | 315,550 | $15,945,000 | 3.12% |
| RA Capital Management | 2,163,271 | $109,310,000 | 2.00% |
| Cormorant Asset Management, LP | 993,185 | $50,186,000 | 1.93% |
| Parkman Healthcare Partners LLC | 41,091 | $2,076,000 | 0.55% |
| Perceptive Advisors | 686,922 | $34,710,000 | 0.51% |
| Redmile Group, LLC | 466,205 | $23,557,000 | 0.43% |
| Eventide Asset Management | 317,417 | $16,039,000 | 0.31% |
| Ikarian Capital, LLC | 63,011 | $3,184,000 | 0.23% |